Liposome-mediated amplified detection of cell-secreted matrix metalloproteinase-9
Chemical Communications2010Vol. 46(18), pp. 3209–3209
Citations Over Time
Jayati Banerjee, Andrea Hanson, Erin K. Nyren‐Erickson, Bratati Ganguli, Anil Wagh, Wallace W. Muhonen, Benedict Law, John B. Shabb, D. K. Srivastava, Sanku Mallik
Abstract
A liposome-based amplified detection system is presented for the cancer cell secreted pathogenic enzyme matrix metalloproteinase-9 which does not require the use of biological antibodies.
Related Papers
- → Binding of Active (57 kDa) Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) to Tissue Inhibitor of Metalloproteinase (TIMP)-2 Regulates MT1-MMP Processing and Pro-MMP-2 Activation(2000)307 cited
- → Expanding the Activity of Tissue Inhibitors of Metalloproteinase (TIMP)-1 against Surface-Anchored Metalloproteinases by the Replacement of Its C-Terminal Domain: Implications for Anti-Cancer Effects(2015)15 cited
- → Complement Dependent and Independent Liposome Uptake by Peritoneal Macrophages: Cholesterol Content Dependency.(1998)17 cited
- → Expression and activation of matrix metalloproteinase‐2 (MMP‐2) and its co‐localization with membrane‐type 1 matrix metalloproteinase (MT1‐MMP) correlate with melanoma progression(2000)7 cited
- Expression of Matrix Metalloproteinase (MMP) and Tissue Inhibitors of Metalloproteinase (TIMP) mRNA in Conjunctival Melanoma Cell Lines(2007)